The hLEC cells were plated in a six-well plate and treated with EBM-2 or Hep-2 conditioned medium for 48 h. Then the cells were collected and used to extract protein and RNA for correlation detection (western blot analysis and qRT-PCR).
Hep 2
The Hep-2 is a laboratory equipment used for the detection and identification of antinuclear antibodies (ANAs) in human serum samples. It is a cell-based indirect immunofluorescence assay (IFA) system that utilizes Hep-2 cells as the substrate. The Hep-2 system provides a standardized method for the screening and semi-quantitative analysis of ANAs, which are associated with various autoimmune disorders.
Lab products found in correlation
13 protocols using hep 2
Human Oral Cancer Cell Interactions
The hLEC cells were plated in a six-well plate and treated with EBM-2 or Hep-2 conditioned medium for 48 h. Then the cells were collected and used to extract protein and RNA for correlation detection (western blot analysis and qRT-PCR).
Cultured Human Cancer Cell Lines
Cultivation of HEp-2 Cervical Carcinoma Cells
Evaluation of Esculetin and STAT3 Modulators in Laryngeal Cancer
Esculetin was purchased from Sigma-Aldrich (99.99% purity) as 100 mM stock solution, and cisplatin was also purchased from Sigma-Aldrich. STAT3 inhibitor C188-9 was purchased from Selleck Chemicals (Houston, TX, USA) and the STAT3 activator colivelin was purchased from Santa Cruz Biotechnology (Dallas, TX, USA). In an in vitro study, Esc, C188-9, and cisplatin were serially diluted with RPMI Medium 1640 triple and triple. Final working concentrations were 0.0457, 0.1369, 0.4120, 1.229, 3.700, 11.10, and 33.29 μM and the highest working concentration was 100 μM.
Culturing Human Laryngeal Carcinoma Hep-2 Cells
Establishing Cisplatin-Resistant Cell Lines
Cisplatin-resistant Hep-2 cells (Hep-2/R) and TU-177 cells (TU-177/R) were established by the incubation of Hep-2 and TU-177 with stepwise increased concentrations of cisplatin as previously described method (22 (link)).
Culturing Human Laryngeal Cancer Cells
Laryngeal Cancer Cell Lines Profiling
Culturing LSCC Hep-2 Human Epithelial Cells
Modulating circZNF609 and miR-134-5p in LSCC Cell Lines
Cell transfection was carried out when cells in culture reached 60–80% confluence using Lipofectamine® 2000. Small interfering RNAs (siRNAs) targeting circZNF609#1 (si-circZNF609#1, 5ʹ-GTCAAGTCTGAAAAGCAATGA-3ʹ), circZNF609#2 (5ʹ-TGCCCTAGTACTACCCTGCAT-3ʹ) and circZNF609#3 (5’-TTGACTGCATCGTAGCCAAAC-3’) and negative control (si-NC, 5’-UUCUCCGAACGUGUCACGUTT-3’) were purchased from Shanghai GenePharma Co., Ltd. The miR-134-5p mimetic, agomir and controls were purchased from Guangzhou RiboBio Co., Ltd. The transfection concentrations of oligonucleotides were as follows: si-NC, 40 nM; si- circZNF609, 40 nM; si-NC, 40 nM; si-EGFR, 40 nM; miR-134-5p mimetic, 50 nM; and miRNA control, agomir and miRNA control, 50 nM. Lipofectamine® 2000 Reagent and si-RNAs or miR-mimic were diluted with serum-free DMEM medium, mixed together and incubated at room temperature for 20 min. This solution was subsequently added to LSC-1 and Hep-2 cells for transfection at 37°C for 4–6 h in a humidified incubator containing 5% CO2.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!